Indian Medical Association

Sight Sciences Announces 1,000th TearCare® Customer Installation

Retrieved on: 
Thursday, January 26, 2023

MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced today the 1,000th installation of its TearCare® System.

Key Points: 
  • MENLO PARK, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, announced today the 1,000th installation of its TearCare® System.
  • In 2019 Sight Sciences commercialized the TearCare® System with the knowledge that doctors, and patients were seeking improvements beyond those provided by current over the counter, prescription pharmaceutical, or in-office treatments for dry eye.
  • Desired improvements included faster action, enduring results and, in the case of in-office treatment, a price point allowing more practices to equip their offices.
  • Immediately following launch, Sight Sciences took the first step required to obtain access to coverage and payment for dry eye sufferers when the American Medical Association (AMA) granted a temporary procedural code specifically describing the open eye TearCare® procedure.

New CPT Code Now Effective for Second Level of Lumbar Total Disc Replacement Procedures

Retrieved on: 
Wednesday, January 18, 2023

To increase the availability of two-level lumbar total disc replacement (TDR) to individuals experiencing degeneration of the intervertebral discs, the American Medical Association (AMA) accepted the addition of a new Category I CPT code for a second level of lumbar TDR in late 2021.

Key Points: 
  • To increase the availability of two-level lumbar total disc replacement (TDR) to individuals experiencing degeneration of the intervertebral discs, the American Medical Association (AMA) accepted the addition of a new Category I CPT code for a second level of lumbar TDR in late 2021.
  • Centinel Spine's prodisc® L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine.
  • New CPT codes are created after review by the AMA CPT Editorial Panel and minimally meet several criteria, including:
    The device is FDA approved.
  • "This new CPT code will allow more patients access to two-level lumbar total disc replacement," commented Dr. Vivek Mohan, MD from the Orthopaedic Spine Institute, Schaumburg, IL.

My Future Consulting Recognized as Top Chicagoland Employment Agency

Retrieved on: 
Monday, January 16, 2023

ORLAND PARK, Ill., Jan. 16, 2023 /PRNewswire/ -- My Future Consulting (MFC), a diversity cognizant search and recruitment firm, has earned its 6th consecutive yearly award from Expertise.com. MFC is recognized as a Top Chicagoland Employment Agency among the over 680 area agencies. Along with its leadership in diversity recruitment, MFC continues to deliver exceptional candidates to major industries which has earned it a place on the Expertise.com "Best of" Award in the past six consecutive years.

Key Points: 
  • ORLAND PARK, Ill., Jan. 16, 2023 /PRNewswire/ -- My Future Consulting (MFC), a diversity cognizant search and recruitment firm, has earned its 6th consecutive yearly award from Expertise.com .
  • MFC is recognized as a Top Chicagoland Employment Agency among the over 680 area agencies.
  • Founded by Anthony Fletcher, Sr. almost two decades ago MFC reflects its passion for diversity, retention, and exceptionalism in its own staff.
  • "I am humbled, pleased, and excited to be recognized as a Top Local Employment Agencies in Chicagoland by Expertise.com for six years in a row.

COEUS Holdings Names Dean Hakanson, MD Chief Medical Officer

Retrieved on: 
Wednesday, January 11, 2023

COEUS Holdings and its subsidiaries (“COEUS”), together a leading health outcomes, contracting, technology, and commercial insights consulting firm, today announced it has appointed Dean Hakanson, MD, to the role of Chief Medical Officer.

Key Points: 
  • COEUS Holdings and its subsidiaries (“COEUS”), together a leading health outcomes, contracting, technology, and commercial insights consulting firm, today announced it has appointed Dean Hakanson, MD, to the role of Chief Medical Officer.
  • He joins COEUS following a period of rapid expansion during which the company has experienced double-digit year-over-year growth in both revenue and head count for the last ten years.
  • “We’re thrilled to have Dr. Hakanson join COEUS as our Chief Medical Officer – a critical position – as we continue our rapid growth,” said Marc Hixson, CEO, at COEUS.
  • Dr. Hakanson is a Diplomate of the American Board of Anesthesiology and the American Medical Association and is currently licensed to practice medicine in California.

American Medical Association (AMA) Grants Journey Biosciences CPT® PLA Code for Novel Predictive Test for Diabetes-Related Kidney Disease

Retrieved on: 
Monday, January 9, 2023

LEBANON, N.H., Jan. 9, 2023 /PRNewswire/ -- Journey Biosciences, a biotechnology innovator of predictive screenings for diabetes-related complications, today announced that a dedicated CPT PLA code, 0384U, has been assigned for its flagship product, NaviDKD, by the American Medical Association (AMA). This milestone marks a significant step toward payer billing and payment, and enables broader adoption of the innovative predictive diagnostic platform.

Key Points: 
  • LEBANON, N.H., Jan. 9, 2023 /PRNewswire/ -- Journey Biosciences , a biotechnology innovator of predictive screenings for diabetes-related complications, today announced that a dedicated CPT PLA code, 0384U, has been assigned for its flagship product, NaviDKD, by the American Medical Association (AMA).
  • This milestone marks a significant step toward payer billing and payment, and enables broader adoption of the innovative predictive diagnostic platform.
  • Already clinically validated in major studies for both type 1 and type 2 diabetes, the CPT PLA code assignment removes a key barrier to accelerating the commercialization of NaviDKD.
  • NaviDKD analyzes blood biomarkers to assign a 10-year risk score for developing diabetes-related kidney disease.

Northwestern Mutual: Ways to Use a Guaranteed Death Benefit

Retrieved on: 
Monday, January 2, 2023

MILWAUKEE, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Northwestern Mutual: Policyholders of universal life insurance and whole life insurance likely know that the policy features a guaranteed death benefit.

Key Points: 
  • MILWAUKEE, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Northwestern Mutual: Policyholders of universal life insurance and whole life insurance likely know that the policy features a guaranteed death benefit.
  • For policyholders thinking about how to distribute their guaranteed death benefit, here are some options:
    Leave it to a spouse: A spouse is usually the first person a policyholder would think of when it comes to leaving behind a death benefit.
  • Couples in retirement, with fewer debts and financial responsibilities, might decide to divvy the death benefit up amongst other relatives.
  • Leave it to grandchildren: Similar to leaving the death benefit to children, some grandparents opt to leave the death benefit to their grandchildren.

Aspira Women’s Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing Portfolio

Retrieved on: 
Tuesday, December 27, 2022

AUSTIN, Texas, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced that the 2023 Omnibus Spending Bill passed by Congress and awaiting President Biden’s signature contains language directing the Center for Medicare & Medicaid Services (CMS) to cover multi-marker tests for ovarian cancer. The company believes all of its commercially available ovarian cancer risk assessment blood tests would fall under the recommended coverage expansion, which is expected to significantly increase access for women with pelvic masses in both Medicare and Medicare Advantage plans. It also sets the stage for commercial payers to adopt similar coverage policies.

Key Points: 
  • Connecticut Rep. Rosa DeLauro, Chair of the House Appropriations Committee stated, “The fight against ovarian cancer is very personal to me.
  • I am a more than 30-year survivor of the disease, but consider myself lucky that it was caught and treated early.
  • Greg Richard, Senior Vice President of Market Access and Business Development at Aspira, stated, “Expanding insurance coverage for our OvaSuite product portfolio is critical to improved patient outcomes and to Aspira’s success.
  • Taken together, though, they demonstrate powerful momentum towards achieving our reimbursement and access goals for both Ova1Plus and OvaWatch.”

The Future of Remote Medicine: The AMA Presents a Framework for Measuring Telehealth Quality

Retrieved on: 
Tuesday, January 3, 2023

WALTHAM, Mass., Jan. 3, 2023 /PRNewswire-PRWeb/ -- Under the simultaneous pressures of a pandemic-driven explosion in the use of telehealth, a growing emphasis on value-based care, and the current state of medical technology, the healthcare industry is undergoing what appear to be fundamental changes as a consequence of the high and irreversible growth of telehealth. The evolution of medical technology enables effective virtual care in the home for patients with increasingly serious conditions. Stuart Long, CEO of InfoBionic, observes, "One of the most important lessons we learned is that telehealth and virtual care are really important augmentations to our healthcare matrix, and they're here to stay." InfoBionic is pioneering the first virtual care, hospital-grade telemetry platform capable of supporting low- to high-acuity cardiac patients anywhere virtual care is delivered.

Key Points: 
  • InfoBionic is pioneering the first virtual care, hospital-grade telemetry platform capable of supporting low- to high-acuity cardiac patients anywhere virtual care is delivered.
  • (1) The adoption of the latest technology is essential to the expansion of telehealth beyond routine patient care.
  • Medicare visits conducted through telehealth increased 63-fold in one year, from approximately 840,000 in 2019 to 52.7 million in 2020.
  • (2) In 2021, 37% of adults in the United States used telehealth for appointments or communication with healthcare professionals.

Oak Street Health Achieves Highest Net Savings of Any Direct Contracting Entity in 2021

Retrieved on: 
Monday, December 19, 2022

Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced that the company achieved the highest net savings out of 53 Direct Contracting Entities (DCEs) in the Global and Professional Direct Contracting (GPDC) Model for the 2021 performance year, while earning the highest possible quality score of 100%.

Key Points: 
  • Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced that the company achieved the highest net savings out of 53 Direct Contracting Entities (DCEs) in the Global and Professional Direct Contracting (GPDC) Model for the 2021 performance year, while earning the highest possible quality score of 100%.
  • Oak Street Health also achieved the second-highest net savings rate at 15.47% and third highest gross savings rate at 17.78%.
  • In Performance Year 2021, the model generated approximately $70 million in net savings for Medicare, with 38 of 53 DCEs earning shared savings.
  • Oak Street Health has built its entire model around bringing high-quality primary care to communities where it is needed most.

House Rx Partners with National Cancer Care Alliance to Provide Oncology Care Teams with New Insights to Improve Specialty Medication Dispensing

Retrieved on: 
Tuesday, December 20, 2022

Patients who are able fill their specialty medication prescriptions through the clinic where they receive their medical care typically experience better health outcomes .

Key Points: 
  • Patients who are able fill their specialty medication prescriptions through the clinic where they receive their medical care typically experience better health outcomes .
  • The company works with clinics all over the U.S. to help them adopt — or improve performance in — specialty drug dispensing operations, known as "medically integrated dispensing".
  • "We're partnering with House Rx to give care teams a new level of insight to help them understand how to improve accessibility of medication for their patients."
  • "Our partnership with the National Cancer Care Alliance will provide the insights needed to help clinics evaluate and improve the care they provide."